QUICKLINKS AND VIEW OPITONS
Two cholesterol drugs, Zocor plus Zetia, increased the risk of cancer by 48% - Part 2
Friday, May 29, 2009 1:05 pm Email this article
How many doctors and patients would view the recommendations on cholesterol differently if they knew that 8 out of 9 of the scientists on the National Cholesterol Education Program (NCEP) panel, which is a group from the U.S. National Institutes of Health (NIH) that has issued national recommendations on cholesterol levels and who should be taking these drugs, have taken money or stocks or stock options by the drug companies selling these drugs?
What if a drug company paid you $10,000 or $50,000 or $100,000…
or paid you $10, 000 or $50,000 or $100,000 a year to be on their “scientific advisory board”...
or gave you stock or stock options which might make you rich if you could convince more doctors to prescribe these drugs.
Do you think this might influence what you might say?
Do you think that you might look for data that supports the use of these drugs?
Do you think that you might ignore data that does not support the use of these drugs?
Do you think that you might try to find a way to “explain away” any problems with these drugs?
Do you think that you might rationalize all of this in your head by telling yourself that “I’m just trying to help mankind,” rather than admit to yourself that the money is affecting what you say?
And if you look around and saw that all the other scientists were saying the same thing, do you think that you might simply go along with it?
But there is good news.
There is something you can do to reduce your risk of heart attack, stroke and death.
And it’s effective.
As far as I know Niacin is the ONLY cholesterol-lowering agent EVER found to reduce the total risk of death.
A 1975 study of 8,341 men who had suffered a heart attack, found that…
Niacin reduced the risk of a second heart attack by 26%.
Niacin reduced the risk of stroke by 27%.
And niacin reduce the dying by 11% over the next 15 years.
Again, as far as I know, niacin is the ONLY cholesterol-modifying agent EVER shown to reduce the risk of death.
Niacin does NOT increase risk of cancer… as may be the case with these drugs.
Niacin does NOT increase the risk of suicide… as may be the case with these drugs.
Niacin does NOT increase the risk of accidental death… as may be the case with these drugs.
Niacin does NOT increase the risk congestive heart failure… as may be the case with these drugs.
Niacin is the only cholesterol-modifying agent I would take and perhaps a fiber supplement, if necessary.
The evidence suggests to me that…
... statins should NEVER be given to people over the age of 65.
... statins should NEVER be given to women of any age.
... statins should NEVER be given to anyone at risk for congestive heart failure.
... statins should NEVER be given to anyone with aortic valve stenosis.
... statins should NEVER be given to anyone with Parkinson’s Disease.
... statins should NEVER be given to anyone who is at an increased risk of cancer.
These drugs should NEVER be given to anyone—the only group left is middle-aged men who have confirmed heart disease—unless you are completely convinced that these drugs have been proven to reduce the TOTAL RISK OF DEATH for someone just like you.
The evidence suggests to me that niacin is a MUCH better choice for the overwhelming majority of people.
One more thing.
Linus Pauling, PhD, a brilliant, two-time Nobel Prize-winning chemist, took niacin and large doses of other nutrients, and lived to be 93-years-old.
You can read about Linus Pauling on Wikipedia.
http://en.wikipedia.org/wiki/Linus_Pa Abram… Hoffer, MD, who discovered niacin’s effects on cholesterol levels, has been taking large doses of niacin for 50 years, and is still alive at the age of 92 (as of 2009).
He credits the fact that he is still alive because of niacin.
You can also read about Dr. Abram Hoffer on Wikipedia.
Rossebo A, Pedersen T, Boman K, Brudi P, Chambers J, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi Y, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 Sep 25, 359(13):1343-56.
AUTHOR’S CONTACT INFORMATION
Division of Cardiology
Aker University Hospital
N-0514 Oslo, Norway
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.